id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT00967785
|
27:32:chronic_disease
|
Absence of a diagnosis of WHIMS
| 1
|
[
"Absence",
"of",
"a",
"diagnosis",
"of",
"WHIMS"
] |
[
0,
0,
0,
0,
0,
2
] |
NCT02329652
|
1:24:chronic_disease
|
urinary tract infection
| 1
|
[
"urinary",
"tract",
"infection"
] |
[
2,
2,
2
] |
NCT02774421
|
30:57:treatment
|
who have previously received solid organ transplantation
| 1
|
[
"who",
"have",
"previously",
"received",
"solid",
"organ",
"transplantation"
] |
[
0,
0,
0,
0,
1,
1,
1
] |
NCT00001337
|
1:4:chronic_disease
|
HIV negative
| 1
|
[
"HIV",
"negative"
] |
[
2,
0
] |
NCT00914823
|
4:20:chronic_disease
|
no chronic diseases
| 1
|
[
"no",
"chronic",
"diseases"
] |
[
0,
2,
2
] |
NCT01061515
|
41:53:treatment
|
All patients must be consented prior to chemotherapy
| 1
|
[
"All",
"patients",
"must",
"be",
"consented",
"prior",
"to",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03036280
|
48:73:chronic_disease,
|
Participants who have a history of moderate to severe hepatic impairment (eg, Child-Pugh Class B or C)
| 1
|
[
"Participants",
"who",
"have",
"a",
"history",
"of",
"moderate",
"to",
"severe",
"hepatic",
"impairment",
"(",
"eg",
",",
"Child-Pugh",
"Class",
"B",
"or",
"C",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02755896
|
,35:60:treatment
|
Post-menopausal women with status post segmental mastectomy
| 1
|
[
"Post-menopausal",
"women",
"with",
"status",
"post",
"segmental",
"mastectomy"
] |
[
0,
0,
0,
0,
1,
1,
1
] |
NCT02774421
|
28:40:treatment
|
who have been treated with chemotherapy at time of recurrence
| 1
|
[
"who",
"have",
"been",
"treated",
"with",
"chemotherapy",
"at",
"time",
"of",
"recurrence"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02099591
|
49:61:treatment
|
Patients currently receiving the first cycle of chemotherapy
| 1
|
[
"Patients",
"currently",
"receiving",
"the",
"first",
"cycle",
"of",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01967823
|
25:35:cancer
|
PATIENTS WITH MALIGNANT MENINGIOMA
| 1
|
[
"PATIENTS",
"WITH",
"MALIGNANT",
"MENINGIOMA"
] |
[
0,
0,
0,
3
] |
NCT01220583
|
,,,123:132:treatment,
|
Women of childbearing potential and male participants who are sexually active must practice adequate contraception during treatment and for 6 weeks following treatment
| 1
|
[
"Women",
"of",
"childbearing",
"potential",
"and",
"male",
"participants",
"who",
"are",
"sexually",
"active",
"must",
"practice",
"adequate",
"contraception",
"during",
"treatment",
"and",
"for",
"6",
"weeks",
"following",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02355002
|
8:23:treatment,27:42:treatment,,95:112:treatment
|
Use of benzodiazepines or anticonvulsants within 2 weeks prior to study (to be ruled out by a urine drug screen)
| 1
|
[
"Use",
"of",
"benzodiazepines",
"or",
"anticonvulsants",
"within",
"2",
"weeks",
"prior",
"to",
"study",
"(",
"to",
"be",
"ruled",
"out",
"by",
"a",
"urine",
"drug",
"screen",
")"
] |
[
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0
] |
NCT02417701
|
45:119:allergy_name
|
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MLN0128 (TAK-228)
| 1
|
[
"History",
"of",
"allergic",
"reactions",
"attributed",
"to",
"compounds",
"of",
"similar",
"chemical",
"or",
"biologic",
"composition",
"to",
"MLN0128",
"(",
"TAK-228",
")"
] |
[
0,
0,
0,
0,
0,
0,
4,
4,
4,
4,
4,
4,
4,
4,
4,
4,
0,
0
] |
NCT03114020
|
18:33:chronic_disease
|
Individuals with PiMZ deficiency are not allowed in the study
| 1
|
[
"Individuals",
"with",
"PiMZ",
"deficiency",
"are",
"not",
"allowed",
"in",
"the",
"study"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT01653093
|
19:26:chronic_disease
|
Patients who have cardiac
| 1
|
[
"Patients",
"who",
"have",
"cardiac"
] |
[
0,
0,
0,
2
] |
NCT01913106
|
1:21:cancer
|
Second active cancer
| 1
|
[
"Second",
"active",
"cancer"
] |
[
3,
3,
3
] |
NCT02580162
|
1:31:chronic_disease
|
Physical disability or illness in either the participating parent or the child that precludes moderate intensity physical activity
| 1
|
[
"Physical",
"disability",
"or",
"illness",
"in",
"either",
"the",
"participating",
"parent",
"or",
"the",
"child",
"that",
"precludes",
"moderate",
"intensity",
"physical",
"activity"
] |
[
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02520791
|
29:65:treatment
|
Patients who have undergone allogeneic stem cell transplantation
| 1
|
[
"Patients",
"who",
"have",
"undergone",
"allogeneic",
"stem",
"cell",
"transplantation"
] |
[
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT02593110
|
1:23:chronic_disease
|
critical limb ischemia
| 1
|
[
"critical",
"limb",
"ischemia"
] |
[
2,
2,
2
] |
NCT03088072
|
36:61:treatment,67:74:treatment,79:90:treatment
|
A need for on-going treatment with dual antiplatelet therapy with aspirin and clopidogrel
| 1
|
[
"A",
"need",
"for",
"on-going",
"treatment",
"with",
"dual",
"antiplatelet",
"therapy",
"with",
"aspirin",
"and",
"clopidogrel"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
0,
1
] |
NCT02269280
|
1:14:treatment,20:30:treatment,34:45:treatment
|
Prior therapy with decitabine or azacitidine
| 1
|
[
"Prior",
"therapy",
"with",
"decitabine",
"or",
"azacitidine"
] |
[
1,
1,
0,
1,
0,
1
] |
NCT02409316
|
,90:92:treatment,94:103:treatment,105:108:treatment,110:120:treatment
|
At least one site of disease outside of the liver that is seen on standard imaging (e.g. CT, bone scan, MRI, FDG PET/CT)
| 1
|
[
"At",
"least",
"one",
"site",
"of",
"disease",
"outside",
"of",
"the",
"liver",
"that",
"is",
"seen",
"on",
"standard",
"imaging",
"(",
"e.g",
".",
"CT",
",",
"bone",
"scan",
",",
"MRI",
",",
"FDG",
"PET/CT",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
1,
0,
1,
1,
0
] |
NCT02585973
|
21:44:chronic_disease
|
severe uncontrolled ventricular arrhythmias
| 1
|
[
"severe",
"uncontrolled",
"ventricular",
"arrhythmias"
] |
[
0,
0,
2,
2
] |
NCT01893554
|
20:57:chronic_disease,98:101:chronic_disease,118:178:treatment,183:217:treatment,230:246:treatment,248:267:treatment,273:303:treatment
|
Known or suspected impairment of immunological functions, including maternal history of positive HIV test, receiving immunosuppressive therapy including systemic corticosteroids, or bone marrow/solid organ transplant recipients (topical steroids, topical antibiotics, and topical antifungal medications are acceptable)
| 1
|
[
"Known",
"or",
"suspected",
"impairment",
"of",
"immunological",
"functions",
",",
"including",
"maternal",
"history",
"of",
"positive",
"HIV",
"test",
",",
"receiving",
"immunosuppressive",
"therapy",
"including",
"systemic",
"corticosteroids",
",",
"or",
"bone",
"marrow/solid",
"organ",
"transplant",
"recipients",
"(",
"topical",
"steroids",
",",
"topical",
"antibiotics",
",",
"and",
"topical",
"antifungal",
"medications",
"are",
"acceptable",
")"
] |
[
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
1,
1,
1,
1,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03099590
|
13:25:chronic_disease,27:37:chronic_disease,42:60:chronic_disease
|
Presence of neurological, infectious, or neoplastic disease
| 1
|
[
"Presence",
"of",
"neurological",
",",
"infectious",
",",
"or",
"neoplastic",
"disease"
] |
[
0,
0,
2,
0,
2,
0,
0,
2,
2
] |
NCT00924027
|
41:80:treatment
|
Patients currently receiving concurrent investigational chemotherapeutic agents
| 1
|
[
"Patients",
"currently",
"receiving",
"concurrent",
"investigational",
"chemotherapeutic",
"agents"
] |
[
0,
0,
0,
0,
1,
1,
1
] |
NCT00819208
|
63:75:treatment
|
patients who are pre-planned to receive a shorter duration of chemotherapy, including as part of a research study
| 1
|
[
"patients",
"who",
"are",
"pre-planned",
"to",
"receive",
"a",
"shorter",
"duration",
"of",
"chemotherapy",
",",
"including",
"as",
"part",
"of",
"a",
"research",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02376153
|
1:39:treatment
|
vascular prosthetic graft implantation
| 1
|
[
"vascular",
"prosthetic",
"graft",
"implantation"
] |
[
1,
1,
1,
1
] |
NCT02706353
|
7:17:cancer
|
Prior malignancy
| 1
|
[
"Prior",
"malignancy"
] |
[
0,
3
] |
NCT02321501
|
21:26:cancer,45:67:treatment,71:82:treatment,,116:120:treatment
|
Patient will have a tumor suitable for fine needle aspirates (FNA) or core biopsy for research purposes (2 or more FNAs if core is not feasible)
| 1
|
[
"Patient",
"will",
"have",
"a",
"tumor",
"suitable",
"for",
"fine",
"needle",
"aspirates",
"(",
"FNA",
")",
"or",
"core",
"biopsy",
"for",
"research",
"purposes",
"(",
"2",
"or",
"more",
"FNAs",
"if",
"core",
"is",
"not",
"feasible",
")"
] |
[
0,
0,
0,
0,
3,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT03104699
|
1:19:chronic_disease
|
immunodeficiencies
| 1
|
[
"immunodeficiencies"
] |
[
2
] |
NCT02754752
|
,,39:52:cancer
|
Have a history of stage I, II, or III breast cancer
| 1
|
[
"Have",
"a",
"history",
"of",
"stage",
"I",
",",
"II",
",",
"or",
"III",
"breast",
"cancer"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT02064673
|
26:36:cancer
|
no sign of lymph node or metastatic disease
| 1
|
[
"no",
"sign",
"of",
"lymph",
"node",
"or",
"metastatic",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
3,
0
] |
NCT02833207
|
26:41:chronic_disease
|
Self-reported history of hepatic disease
| 1
|
[
"Self-reported",
"history",
"of",
"hepatic",
"disease"
] |
[
0,
0,
0,
2,
2
] |
NCT02578641
|
1:29:chronic_disease
|
ischemic heart disease (IHD)
| 1
|
[
"ischemic",
"heart",
"disease",
"(",
"IHD",
")"
] |
[
2,
2,
2,
2,
0,
0
] |
NCT02457702
|
1:31:chronic_disease
|
Portal systemic encephalopathy
| 1
|
[
"Portal",
"systemic",
"encephalopathy"
] |
[
2,
2,
2
] |
NCT02266745
|
8:25:chronic_disease
|
Severe liver dysfunction (Child-Pugh Class B or C)
| 1
|
[
"Severe",
"liver",
"dysfunction",
"(",
"Child-Pugh",
"Class",
"B",
"or",
"C",
")"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02558010
|
1:9:allergy_name,11:24:allergy_name,28:37:allergy_name
|
Morphine, hydromorphone or methadone allergies
| 1
|
[
"Morphine",
",",
"hydromorphone",
"or",
"methadone",
"allergies"
] |
[
4,
0,
4,
0,
4,
0
] |
NCT03079297
|
21:40:chronic_disease
|
lifetime history of psychotic disorders
| 1
|
[
"lifetime",
"history",
"of",
"psychotic",
"disorders"
] |
[
0,
0,
0,
2,
2
] |
NCT02737930
|
72:82:treatment
|
Current use of a medication likely to have an adverse interaction with fluoxetine
| 1
|
[
"Current",
"use",
"of",
"a",
"medication",
"likely",
"to",
"have",
"an",
"adverse",
"interaction",
"with",
"fluoxetine"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02465060
|
1:25:chronic_disease,29:49:treatment,54:62:treatment
|
Unstable angina pectoris or coronary angioplasty, or stenting
| 1
|
[
"Unstable",
"angina",
"pectoris",
"or",
"coronary",
"angioplasty",
",",
"or",
"stenting"
] |
[
2,
2,
2,
0,
1,
1,
0,
0,
1
] |
NCT01959698
|
65:78:treatment,80:97:treatment,99:111:treatment,116:129:treatment
|
Patients must not have any significant toxicity associated with prior surgery, radiation therapy, chemotherapy, or immunotherapy, per principal investigator (PI) discretion
| 1
|
[
"Patients",
"must",
"not",
"have",
"any",
"significant",
"toxicity",
"associated",
"with",
"prior",
"surgery",
",",
"radiation",
"therapy",
",",
"chemotherapy",
",",
"or",
"immunotherapy",
",",
"per",
"principal",
"investigator",
"(",
"PI",
")",
"discretion"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02112617
|
20:23:treatment,31:33:treatment,,82:91:treatment,102:120:treatment,125:134:treatment,141:160:treatment,164:173:treatment,175:184:treatment,188:197:treatment
|
Diagnostic Imaging MRI and/or CT of the area to be treated within 8 weeks of any treatment. Baseline bone marrow biopsy and bone scan (with 99mTc-diphosphonate or MIBG scan (131I-MIBG or 123I-MIBG) from time of original diagnosis is required
| 1
|
[
"Diagnostic",
"Imaging",
"MRI",
"and/or",
"CT",
"of",
"the",
"area",
"to",
"be",
"treated",
"within",
"8",
"weeks",
"of",
"any",
"treatment",
".",
"Baseline",
"bone",
"marrow",
"biopsy",
"and",
"bone",
"scan",
"(",
"with",
"99mTc-diphosphonate",
"or",
"MIBG",
"scan",
"(",
"131I-MIBG",
"or",
"123I-MIBG",
")",
"from",
"time",
"of",
"original",
"diagnosis",
"is",
"required"
] |
[
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03035773
|
1:9:cancer,13:30:cancer,37:50:cancer
|
prostate or colorectal cancer (i.e. Stage 0 or IV)
| 1
|
[
"prostate",
"or",
"colorectal",
"cancer",
"(",
"i.e",
".",
"Stage",
"0",
"or",
"IV",
")"
] |
[
3,
0,
3,
3,
0,
0,
0,
3,
3,
3,
3,
0
] |
NCT02133898
|
1:52:treatment
|
repetitive transcranial magnetic stimulation (rTMS)
| 1
|
[
"repetitive",
"transcranial",
"magnetic",
"stimulation",
"(",
"rTMS",
")"
] |
[
1,
1,
1,
1,
1,
0,
0
] |
NCT03036280
|
19:55:treatment,
|
Have received any live vaccine/live attenuated vaccine in the 3 months before randomization
| 1
|
[
"Have",
"received",
"any",
"live",
"vaccine/live",
"attenuated",
"vaccine",
"in",
"the",
"3",
"months",
"before",
"randomization"
] |
[
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT03019367
|
1:21:chronic_disease
|
Congenital anomalies
| 1
|
[
"Congenital",
"anomalies"
] |
[
2,
2
] |
NCT02509507
|
12:39:treatment
|
history of solid organ transplantation
| 1
|
[
"history",
"of",
"solid",
"organ",
"transplantation"
] |
[
0,
0,
1,
1,
1
] |
NCT02561104
|
10:18:chronic_disease
|
advanced glaucoma
| 1
|
[
"advanced",
"glaucoma"
] |
[
0,
2
] |
NCT02244814
|
12:24:chronic_disease
|
History of pancreatitis
| 1
|
[
"History",
"of",
"pancreatitis"
] |
[
0,
0,
2
] |
NCT03166371
|
9:17:chronic_disease
|
Current dementia
| 1
|
[
"Current",
"dementia"
] |
[
0,
2
] |
NCT00573027
|
1:15:chronic_disease
|
LV dysfunction
| 1
|
[
"LV",
"dysfunction"
] |
[
2,
2
] |
NCT02468024
|
1:6:cancer
|
Tumor located peripherally within the lung
| 1
|
[
"Tumor",
"located",
"peripherally",
"within",
"the",
"lung"
] |
[
3,
0,
0,
0,
0,
0
] |
NCT02536794
|
74:86:cancer
|
Patients must have measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) criteria
| 1
|
[
"Patients",
"must",
"have",
"measurable",
"disease",
"by",
"Response",
"Evaluation",
"Criteria",
"in",
"Solid",
"Tumors",
"(",
"RECIST",
")",
"criteria"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0
] |
NCT02913495
|
7:20:chronic_disease,34:44:treatment,54:74:chronic_disease
|
Major fetal anomaly diagnosed on ultrasound or known chromosomal disorder
| 1
|
[
"Major",
"fetal",
"anomaly",
"diagnosed",
"on",
"ultrasound",
"or",
"known",
"chromosomal",
"disorder"
] |
[
0,
2,
2,
0,
0,
1,
0,
0,
2,
2
] |
NCT01972113
|
20:38:treatment,42:59:treatment,121:132:treatment,134:145:treatment
|
Subjects receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters (salicylates, antibiotics)
| 1
|
[
"Subjects",
"receiving",
"systemic",
"treatment",
"or",
"topical",
"treatment",
"likely",
"to",
"interfere",
"with",
"evaluation",
"of",
"the",
"study",
"parameters",
"(",
"salicylates",
",",
"antibiotics",
")"
] |
[
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0
] |
NCT02509260
|
1:21:treatment
|
intestinal resection
| 1
|
[
"intestinal",
"resection"
] |
[
1,
1
] |
NCT02180412
|
52:96:treatment,
|
Most (~90 percent) will have deficient activity of erythrocyte porphobilinogen deaminase (PBGD), and almost all (>95 percent) will have a demonstrable disease-causing PBGD mutation
| 1
|
[
"Most",
"(",
"~90",
"percent",
")",
"will",
"have",
"deficient",
"activity",
"of",
"erythrocyte",
"porphobilinogen",
"deaminase",
"(",
"PBGD",
")",
",",
"and",
"almost",
"all",
"(",
">",
"95",
"percent",
")",
"will",
"have",
"a",
"demonstrable",
"disease-causing",
"PBGD",
"mutation"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02536170
|
1:18:chronic_disease,,
|
Renal dysfunction of creatinine greater than 1.0
| 1
|
[
"Renal",
"dysfunction",
"of",
"creatinine",
"greater",
"than",
"1.0"
] |
[
2,
2,
0,
0,
0,
0,
0
] |
NCT02955251
|
51:62:cancer,80:89:treatment,93:109:treatment
|
combination therapy cohorts must have an advanced solid tumor where the use of nivolumab is standard therapy
| 1
|
[
"combination",
"therapy",
"cohorts",
"must",
"have",
"an",
"advanced",
"solid",
"tumor",
"where",
"the",
"use",
"of",
"nivolumab",
"is",
"standard",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
1,
0,
1,
1
] |
NCT02312596
|
8:21:chronic_disease,61:70:chronic_disease,74:83:chronic_disease,,,,,,
|
Severe liver disease is defined as known history of chronic hepatitis or cirrhosis &/or the following abnormal Liver Function Tests: ALT & AST >35, ALP >120, PT >12 seconds
| 1
|
[
"Severe",
"liver",
"disease",
"is",
"defined",
"as",
"known",
"history",
"of",
"chronic",
"hepatitis",
"or",
"cirrhosis",
"&",
"/or",
"the",
"following",
"abnormal",
"Liver",
"Function",
"Tests",
":",
"ALT",
"&",
"AST",
">",
"35",
",",
"ALP",
">",
"120",
",",
"PT",
">",
"12",
"seconds"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00472329
|
,,,,99:108:treatment
|
Fertile men or women unwilling to use contraceptive techniques during and for 12 months following treatment
| 1
|
[
"Fertile",
"men",
"or",
"women",
"unwilling",
"to",
"use",
"contraceptive",
"techniques",
"during",
"and",
"for",
"12",
"months",
"following",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01553071
|
49:62:treatment
|
Patients must have recovered from toxicities of prior therapy
| 1
|
[
"Patients",
"must",
"have",
"recovered",
"from",
"toxicities",
"of",
"prior",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02463305
|
14:23:chronic_disease
|
Diagnosis of severe UC
| 1
|
[
"Diagnosis",
"of",
"severe",
"UC"
] |
[
0,
0,
2,
2
] |
NCT01614990
|
38:50:treatment
|
subjects may otherwise be undergoing chemotherapy
| 1
|
[
"subjects",
"may",
"otherwise",
"be",
"undergoing",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
1
] |
NCT01822522
|
,68:77:treatment
|
Any of the following within 28 days before the first dose of study treatment
| 1
|
[
"Any",
"of",
"the",
"following",
"within",
"28",
"days",
"before",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01954576
|
1:22:cancer
|
Infra-tentorial tumor
| 1
|
[
"Infra-tentorial",
"tumor"
] |
[
3,
3
] |
NCT02796391
|
1:4:treatment
|
THC will be tested but will not be an exclusionary criterion
| 1
|
[
"THC",
"will",
"be",
"tested",
"but",
"will",
"not",
"be",
"an",
"exclusionary",
"criterion"
] |
[
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01459107
|
14:24:cancer,
|
Negative for malignancy for past 5 years
| 1
|
[
"Negative",
"for",
"malignancy",
"for",
"past",
"5",
"years"
] |
[
0,
0,
3,
0,
0,
0,
0
] |
NCT03071692
|
13:32:chronic_disease,38:63:chronic_disease,65:74:chronic_disease,76:111:chronic_disease,116:132:treatment,,
|
Symptomatic lower extremity PAD (ie, intermittent claudication, rest pain, lower extremity ischemic ulceration, or major amputation with either ankle-brachial index ≤ 0.9 or other diagnostic testing [eg, toe-brachial index, angiogram, or other imaging study])
| 1
|
[
"Symptomatic",
"lower",
"extremity",
"PAD",
"(",
"ie",
",",
"intermittent",
"claudication",
",",
"rest",
"pain",
",",
"lower",
"extremity",
"ischemic",
"ulceration",
",",
"or",
"major",
"amputation",
"with",
"either",
"ankle-brachial",
"index",
"≤",
"0.9",
"or",
"other",
"diagnostic",
"testing",
"[",
"eg",
",",
"toe-brachial",
"index",
",",
"angiogram",
",",
"or",
"other",
"imaging",
"study",
"]",
")"
] |
[
0,
2,
2,
2,
2,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03019133
|
8:20:treatment
|
Use of vasopressors
| 1
|
[
"Use",
"of",
"vasopressors"
] |
[
0,
0,
1
] |
NCT02273375
|
128:137:treatment
|
Investigators must assure themselves the patients randomized on this trial will be available for complete documentation of the treatment, adverse events, and follow-up
| 1
|
[
"Investigators",
"must",
"assure",
"themselves",
"the",
"patients",
"randomized",
"on",
"this",
"trial",
"will",
"be",
"available",
"for",
"complete",
"documentation",
"of",
"the",
"treatment",
",",
"adverse",
"events",
",",
"and",
"follow-up"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01430390
|
43:73:treatment
|
There is no time restriction in regard to prior intrathecal chemotherapy provided tere is complete recovery from any acute toxic effects of such
| 1
|
[
"There",
"is",
"no",
"time",
"restriction",
"in",
"regard",
"to",
"prior",
"intrathecal",
"chemotherapy",
"provided",
"tere",
"is",
"complete",
"recovery",
"from",
"any",
"acute",
"toxic",
"effects",
"of",
"such"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02412540
|
19:50:chronic_disease,,
|
Poorly controlled Type 2 diabetes mellitus (T2DM) defined as hemoglobin A1C (HgbA1c) > 10%
| 1
|
[
"Poorly",
"controlled",
"Type",
"2",
"diabetes",
"mellitus",
"(",
"T2DM",
")",
"defined",
"as",
"hemoglobin",
"A1C",
"(",
"HgbA1c",
")",
">",
"10",
"%"
] |
[
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01906385
|
1:22:chronic_disease,24:30:chronic_disease,32:57:chronic_disease,
|
Myocardial infarction, stroke, transient ischemic attack within 6 months
| 1
|
[
"Myocardial",
"infarction",
",",
"stroke",
",",
"transient",
"ischemic",
"attack",
"within",
"6",
"months"
] |
[
2,
2,
0,
2,
0,
2,
2,
2,
0,
0,
0
] |
NCT02374333
|
114:128:treatment
|
beyond 1st CR with relapsed or persistent disease and not eligible or appropriate for conventional allogeneic or autologous SCT
| 1
|
[
"beyond",
"1st",
"CR",
"with",
"relapsed",
"or",
"persistent",
"disease",
"and",
"not",
"eligible",
"or",
"appropriate",
"for",
"conventional",
"allogeneic",
"or",
"autologous",
"SCT"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03112902
|
1:7:chronic_disease
|
eczema or sensitive skin
| 1
|
[
"eczema",
"or",
"sensitive",
"skin"
] |
[
2,
0,
0,
0
] |
NCT01622868
|
,,,134:150:cancer,
|
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3.0 times institutional upper limit of normal with or without liver metastasis (within 21 days prior to study entry)
| 1
|
[
"Aspartate",
"aminotransferase",
"(",
"AST",
")",
"and",
"alanine",
"aminotransferase",
"(",
"ALT",
")",
"=",
"<",
"3.0",
"times",
"institutional",
"upper",
"limit",
"of",
"normal",
"with",
"or",
"without",
"liver",
"metastasis",
"(",
"within",
"21",
"days",
"prior",
"to",
"study",
"entry",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02464904
|
1:15:treatment,24:35:treatment,37:44:treatment,46:74:treatment,76:84:treatment,94:114:treatment
|
Anticoagulants such as clopidogrel, heparin, low-molecular weight heparin, warfarin or other novel anticoagulants have not been held for the standard time period published
| 1
|
[
"Anticoagulants",
"such",
"as",
"clopidogrel",
",",
"heparin",
",",
"low-molecular",
"weight",
"heparin",
",",
"warfarin",
"or",
"other",
"novel",
"anticoagulants",
"have",
"not",
"been",
"held",
"for",
"the",
"standard",
"time",
"period",
"published"
] |
[
1,
0,
0,
1,
0,
1,
0,
1,
1,
1,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03090607
|
7:30:treatment
|
Prior gastric or GERD surgery
| 1
|
[
"Prior",
"gastric",
"or",
"GERD",
"surgery"
] |
[
0,
1,
1,
1,
1
] |
NCT02021578
|
1:10:chronic_disease
|
Bipolar I (parent or child)
| 1
|
[
"Bipolar",
"I",
"(",
"parent",
"or",
"child",
")"
] |
[
2,
2,
0,
0,
0,
0,
0
] |
NCT02639065
|
99:108:treatment
|
Because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother, breastfeeding should be discontinued
| 1
|
[
"Because",
"there",
"is",
"an",
"unknown",
"but",
"potential",
"risk",
"for",
"adverse",
"events",
"in",
"nursing",
"infants",
"secondary",
"to",
"treatment",
"of",
"the",
"mother",
",",
"breastfeeding",
"should",
"be",
"discontinued"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02656706
|
1:17:cancer,58:80:cancer,90:105:cancer
|
Brain metastases, whether resected or not, and any known leptomeningeal disease or known bone metastases
| 1
|
[
"Brain",
"metastases",
",",
"whether",
"resected",
"or",
"not",
",",
"and",
"any",
"known",
"leptomeningeal",
"disease",
"or",
"known",
"bone",
"metastases"
] |
[
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
3,
3
] |
NCT02053792
|
12:26:chronic_disease
|
congenital FIX deficiency
| 1
|
[
"congenital",
"FIX",
"deficiency"
] |
[
0,
2,
2
] |
NCT03085043
|
28:38:cancer,,
|
Patient is at low risk for metastasis with Gleason score at diagnosis < 8
| 1
|
[
"Patient",
"is",
"at",
"low",
"risk",
"for",
"metastasis",
"with",
"Gleason",
"score",
"at",
"diagnosis",
"<",
"8"
] |
[
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02525692
|
18:28:cancer,68:77:treatment,,105:115:treatment,136:168:cancer,170:205:cancer,210:233:cancer,265:281:treatment
|
Known additional malignancy that is progressing or requires active treatment within 3 years of start of study drug. Exceptions include basal cell carcinoma of the skin, squamous cell carcinoma of the skin, or in situ cervical cancer that has undergone potentially curative therapy
| 1
|
[
"Known",
"additional",
"malignancy",
"that",
"is",
"progressing",
"or",
"requires",
"active",
"treatment",
"within",
"3",
"years",
"of",
"start",
"of",
"study",
"drug",
".",
"Exceptions",
"include",
"basal",
"cell",
"carcinoma",
"of",
"the",
"skin",
",",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
",",
"or",
"in",
"situ",
"cervical",
"cancer",
"that",
"has",
"undergone",
"potentially",
"curative",
"therapy"
] |
[
0,
0,
3,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
3,
3,
3,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
1,
1
] |
NCT00720785
|
1:27:cancer
|
metastatic Ewing's sarcoma
| 1
|
[
"metastatic",
"Ewing",
"'s",
"sarcoma"
] |
[
3,
3,
3,
0
] |
NCT02057133
|
48:63:treatment
|
Participants may be receiving a stable dose of corticosteroids
| 1
|
[
"Participants",
"may",
"be",
"receiving",
"a",
"stable",
"dose",
"of",
"corticosteroids"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02259621
|
7:36:treatment,
|
other immunosuppressive medications within 14 days of study drug administration
| 1
|
[
"other",
"immunosuppressive",
"medications",
"within",
"14",
"days",
"of",
"study",
"drug",
"administration"
] |
[
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02410954
|
13:35:chronic_disease
|
Any current neurological condition
| 1
|
[
"Any",
"current",
"neurological",
"condition"
] |
[
0,
0,
2,
2
] |
NCT02536170
|
213:231:treatment
|
Pain requiring medical care in an acute care setting (such as the emergency department or ED, hospital ward, day hospital, clinic) not attributable to non-sickle cell causes, that is moderate-to-severe requiring parenteral opioids
| 1
|
[
"Pain",
"requiring",
"medical",
"care",
"in",
"an",
"acute",
"care",
"setting",
"(",
"such",
"as",
"the",
"emergency",
"department",
"or",
"ED",
",",
"hospital",
"ward",
",",
"day",
"hospital",
",",
"clinic",
")",
"not",
"attributable",
"to",
"non-sickle",
"cell",
"causes",
",",
"that",
"is",
"moderate-to-severe",
"requiring",
"parenteral",
"opioids"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02576444
|
108:117:treatment
|
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
| 1
|
[
"Patient",
"is",
"willing",
"and",
"able",
"to",
"comply",
"with",
"the",
"protocol",
"for",
"the",
"duration",
"of",
"the",
"study",
"including",
"undergoing",
"treatment",
"and",
"scheduled",
"visits",
"and",
"examinations",
"including",
"follow",
"up"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02004275
|
,17:33:treatment,26:33:treatment,38:54:cancer,47:54:cancer,134:146:treatment,150:169:treatment,202:220:treatment,263:275:treatment,277:287:treatment,292:323:treatment,349:385:treatment,395:427:treatment,458:471:treatment
|
1 prior line of systemic therapy for multiple myeloma, where a line of therapy for myeloma is defined as 1 or more planned cycles of single agent or combination therapy, as well as a planned series of treatment regimens administered in a sequential manner (e.g. lenalidomide, bortezomib and dexamethasone induction therapy for 4 cycles followed by autologous stem cell transplantation and then lenalidomide maintenance therapy would be considered 1 line of prior therapy)
| 1
|
[
"1",
"prior",
"line",
"of",
"systemic",
"therapy",
"for",
"multiple",
"myeloma",
",",
"where",
"a",
"line",
"of",
"therapy",
"for",
"myeloma",
"is",
"defined",
"as",
"1",
"or",
"more",
"planned",
"cycles",
"of",
"single",
"agent",
"or",
"combination",
"therapy",
",",
"as",
"well",
"as",
"a",
"planned",
"series",
"of",
"treatment",
"regimens",
"administered",
"in",
"a",
"sequential",
"manner",
"(",
"e.g",
".",
"lenalidomide",
",",
"bortezomib",
"and",
"dexamethasone",
"induction",
"therapy",
"for",
"4",
"cycles",
"followed",
"by",
"autologous",
"stem",
"cell",
"transplantation",
"and",
"then",
"lenalidomide",
"maintenance",
"therapy",
"would",
"be",
"considered",
"1",
"line",
"of",
"prior",
"therapy",
")"
] |
[
0,
1,
1,
0,
1,
1,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02576431
|
,44:53:treatment
|
Subjects who received less than 28 days of treatment and discontinued because of intolerance or toxicity are eligible
| 1
|
[
"Subjects",
"who",
"received",
"less",
"than",
"28",
"days",
"of",
"treatment",
"and",
"discontinued",
"because",
"of",
"intolerance",
"or",
"toxicity",
"are",
"eligible"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02155946
|
14:26:chronic_disease
|
Diagnosis of amnestic MCI based on criteria set forth by Petersen (2004). Additionally, other potential causes of cognitive deficit ruled out by the referring physician
| 1
|
[
"Diagnosis",
"of",
"amnestic",
"MCI",
"based",
"on",
"criteria",
"set",
"forth",
"by",
"Petersen",
"(",
"2004",
")",
".",
"Additionally",
",",
"other",
"potential",
"causes",
"of",
"cognitive",
"deficit",
"ruled",
"out",
"by",
"the",
"referring",
"physician"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02019641
|
128:155:chronic_disease
|
Other medical conditions that may pose a risk to exercise testing or training as determined by the investigators (for example, peripheral vascular disease)
| 1
|
[
"Other",
"medical",
"conditions",
"that",
"may",
"pose",
"a",
"risk",
"to",
"exercise",
"testing",
"or",
"training",
"as",
"determined",
"by",
"the",
"investigators",
"(",
"for",
"example",
",",
"peripheral",
"vascular",
"disease",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0
] |
NCT02464436
|
28:30:chronic_disease
|
Have clinical diagnosis of RP
| 1
|
[
"Have",
"clinical",
"diagnosis",
"of",
"RP"
] |
[
0,
0,
0,
0,
2
] |
NCT02146924
|
15:30:treatment
|
Dependence on corticosteroids
| 1
|
[
"Dependence",
"on",
"corticosteroids"
] |
[
0,
0,
1
] |
NCT00887146
|
14:24:cancer,
|
Other active malignancy within 5 years of registration
| 1
|
[
"Other",
"active",
"malignancy",
"within",
"5",
"years",
"of",
"registration"
] |
[
0,
0,
3,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.